A Phase 2A Partially-blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Live Attenuated, Intranasal B. Pertussis Vaccine (BPZE1) in Healthy Adults
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2018
At a glance
- Drugs BPZE 1 (Primary)
- Indications Pertussis
- Focus Adverse reactions
- 02 Aug 2018 Planned initiation date changed from 26 Jul 2018 to 3 Aug 2018.
- 05 Jul 2018 Planned initiation date changed from 30 Jun 2018 to 26 Jul 2018.
- 17 May 2018 Status changed from planning to not yet recruiting.